Hepatopulmonary syndrome (HPS) is a condition characterized by chronic liver disease,
intrapulmonary arteriovenous shunting, and increased alveolar-arterial oxygen gradient …

Background Hepatopulmonary syndrome (HPS) is characterized by an arterial oxygenation
defect, defined by an increased alveolar-arterial oxygen gradient, induced by pulmonary …

Pulmonary syndromes in the setting of hepatic disease with portal hypertension include
portopulmonary hypertension (POPH), hepatopulmonary syndrome (HPS) and hepatic …

abstract Pulmonary syndromes in the setting of hepatic disease with portal hypertension
include portopulmonary hypertension (POPH), hepatopulmonary syndrome (HPS) and …

Hepatopulmonary syndrome (HPS) and portopulmonary hypertension (PPHTN) are the two
major pulmonary vascular complications of liver disease. While HPS is characterized by low …

Background Hepatopulmonary syndrome (HPS) is characterized by hypoxemia associated
with intrapulmonary vascular dilatation (IPVD) usually in the context of chronic liver disease …

Background: The hepatopulmonary syndrome (HPS) is defined as the triad of liver disease,
arterial deoxygenation, and pulmonary vascular dilatation. The reported prevalence of HPS …

Hepatopulmonary syndrome (HPS) is a serious vascular complication of liver disease that
occurs in 5–32% of patients with cirrhosis. The presence of HPS markedly increases …

The hepatopulmonary syndrome (HPS) is a reversible pulmonary insufficiency in
association with liver disease, most frequently liver cirrhosis. The pathogenesis of HPS is …

Hepatopulmonary syndrome (HPS) and pulmonary arteriovenous malformation (PAVM) are
hypoxemic diseases caused by right-to-left shunting but are rarely concomitant with …